Obinutuzumab Plus Chlorambucil in a Patient with Severe Myasthenia Gravis and Chronic Lymphocytic Leukemia.

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, characterized by fatigable weakness of the extraocular, bulbar, and limb musculature; prevalence is estimated at 14 to 32 per 100,000 in North America. Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, resulting from clonal expansion of B-cells in blood, marrow, and secondary lymphoid tissues. The simultaneous presentation of MG and CLL is exceedingly rare. This article presents the case of 71-year-old man diagnosed simultaneously with MG and CLL. His MG was severe and refractory to treatment; therefore, a strategy of treating his coexisting CLL with obinutuzumab and chlorambucil was pursued. Following 6 cycles of obinutuzumab and chlorambucil, his CLL is in remission and his MG is almost entirely undetectable. This is the first case report describing the use of obinutuzumab, a novel anti-CD20 monoclonal antibody, in a patient with concurrent MG and CLL.

Muscle and fascicle excursion in children with cerebral palsy.

BACKGROUND: Fascicle length and fascicle excursion measurements in children with cerebral palsy have yielded inconsistent results. The purpose of this study was to measure in vivo passive fascicle lengths and fascicle excursions in the Medial Gastrocnemius muscle of children with cerebral palsy and typically developing controls. METHODS: We measured 11 children with spastic cerebral palsy and 14 controls between the ages of 9 and 16years. Ultrasound imaging was used to measure fascicle lengths while a dynamometer moved the ankle joint through the range of motion. A common range of motion for all subjects was used for analysis of fascicle excursion. FINDINGS: Fascicle lengths in children with cerebral palsy were 43% smaller than those for control subjects throughout the range of motion. The relative fascicle excursion was 92% greater on average for the cerebral palsy compared to the control group children. The muscle excursion for the control group children was greater than for the cerebral palsy group children. INTERPRETATION: Since the fascicles in children with spastic cerebral palsy are shorter, but they go through the same excursion as fascicles in typically developing children, sarcomeres within the medial gastrocnemius muscle must be working over a larger range of sarcomere lengths. Combined with findings of overstretched sarcomeres in spastic muscles reported in the literature, our results suggest that the increased passive forces and the weakness found in spastic muscles may be caused by a decrease in contractile filament overlap as sarcomeres are pulled to extreme lengths in children with cerebral palsy.